Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Early Factor XIII Replacement in Postpartum Hemorrhage: Multi-center, Randomized, Controlled, Investigator-initiated Trial

NCT06481995 is registered in ClinicalTrials.gov with Christian Haslinger as lead sponsor.

NCT NCT06481995
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06481995 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Early Factor XIII Replacement in Postpartum Hemorrhage: Multi-center, Randomized, Controlled, Investigator-initiated Trial
Lead sponsor
Christian Haslinger
Phase
Phase 4
Overall status
Recruiting
Start date
July 9, 2024
Completion date
December 31, 2028
Enrollment
988 (estimated)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

coagulation disorder, coagulation factor deficiency, hemorrhage, postpartum complication, postpartum hemorrhage